Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab.

Autor: Wen C; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Yang J; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Wei D; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Xu C; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Yu P; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Luo L; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China.
Jazyk: angličtina
Zdroj: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Feb 01; Vol. 63 (2), pp. e53-e55.
DOI: 10.1093/rheumatology/kead424
Databáze: MEDLINE